Hytrine

Terazosin, the active ingredient in Hytrine, is an alpha-1 adrenergic blocker presented as an oral formulation for oral use. It is used to manage hypertension and benign prostatic hyperplasia in adult patients. By selectively antagonizing alpha-1 receptors, it helps lower blood pressure and relaxes smooth muscle in the prostate and bladder neck, improving urinary flow.

GNH USA supplies Hytrine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to global quality standards and provides regulatory support for cross‑border distribution.

Terazosin is indicated for conditions involving the cardiovascular and urinary systems where alpha‑1 receptor blockade is beneficial. - Hypertension: lowers systemic vascular resistance to reduce blood pressure. - Benign prostatic hyperplasia: relaxes prostatic smooth muscle to improve urinary flow. - Lower urinary tract symptoms associated with BPH: alleviates urinary frequency and urgency.

Common Side Effects: - Dizziness: feeling light‑headed, especially when standing quickly. - Headache: mild to moderate intensity. - Fatigue: general tiredness or lack of energy. - Nasal congestion: blocked or runny nose. - Peripheral edema: swelling of ankles or feet. - Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure that may cause fainting. - Syncope: sudden loss of consciousness. - Priapism: prolonged, painful erection. - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Hepatic injury: rare liver function abnormalities.

Before initiating therapy, consider the following precautions: - Blood pressure monitoring: check baseline and periodic readings to avoid excessive hypotension. - Renal impairment: assess kidney function and adjust dose if necessary. - Concomitant antihypertensives: monitor for additive blood‑pressure‑lowering effects. - History of orthostatic hypotension: start at the lowest dose and titrate slowly. - Pregnancy and lactation: use only if potential benefit justifies the risk. - Store at ambient temperature: keep below 25°C, protect from moisture and light.

Terazosin may interact with several medicines; awareness of these interactions helps maintain safety. Major Interactions (Avoid): - Sildenafil or other PDE5 inhibitors: risk of severe hypotension. - Potassium‑sparing diuretics: additive blood‑pressure‑lowering effect. - Other alpha‑blockers: excessive vasodilation may occur. Moderate Interactions (Monitor Closely):\n- ACE inhibitors, ARBs, or other antihypertensives: may require dose adjustment. - CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): can increase terazosin plasma levels. - Alcohol: may enhance hypotensive response.